The global food allergy market is likely to reach a valuation of US$ 39.83 Billion in 2023 and is expected to register at a CAGR of 5.2% to reach US$ 66.15 Billion by the end of 2033. By 2023, adrenaline treatment will account for almost 32% of the global market for food allergy treatments.
A large percentage of children and adults suffer from food allergies, with 8% of them being under five years old, and 4% being adults. Even though there is no cure for food allergies, some children outgrow them as they grow up and become more independent.
To assess and manage allergen hazards in food, the FDA offers guidance to food producers, consumers, and other stakeholders. Inspections and sampling by the FDA are also performed to ensure food products are properly labeled for major allergens in addition to ensuring food facilities implement controls to prevent cross-contact of allergens during manufacturing and packaging and that labeling controls prevent undeclared allergens.
A recall is initiated by the FDA after problems with products are found and public notification is provided to alert consumers. In addition to this, the FDA has the power to seize, remove, and refuse to allow the entry of products that violate its regulations from the marketplace, as well as deny imports entry into the country.
| Data Points | Key Statistics |
|---|---|
| Anticipated Base Year Value (2022) | US$ 38 Billion |
| Expected Market Value (2023) | US$ 39.83 Billion |
| Projected Forecast Value (2033) | US$ 66.15 Billion |
| Global Growth Rate (2023 to 2033) | 5.2% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to FMI, food allergy sales grew at a CAGR of 4.8% in the historical period 2018 to 2022. Kids are increasingly suffering from food allergies, which is the latest epidemic of the current generation.
Several allergen-specific and non-specific therapies are under investigation as potential treatment options for people suffering from food allergies; however, in terms of therapeutic outcomes, immunotherapy has been identified as the most promising treatment option for individuals who suffer from food allergies to date. Providing an overview of recent developments in the treatment of food allergies is the objective of this review.
Anaphylaxis is still an unpredictable possibility with food allergies, which continue to increase in prevalence. There are fewer treatment options available, even though diagnostic accuracy is improving. Allergy management relies on avoiding offending allergens and educating patients on how to manage them. Although precautions and vigilance are taken, accidental ingesting continues.
Recent advancements made in the study of humoral and cellular immune responses and tolerance mechanisms in food allergy have led to the development of several therapeutic strategies to treat food allergies in an effort to cure or remit them long term. Accordingly, the market for food allergy is projected to grow at a CAGR of 5.2% between 2023 and 2033.
According to research, asthma incidences are expected to rise from 2023 to 2033. Allergies to food commonly coexist with asthma. There is a greater likelihood that food allergies and asthma symptoms will become severe under these circumstances. The food allergy market growth rate is also influenced by rising healthcare expenditures that help improve its infrastructure. The government is also increasing funding for healthcare infrastructure, which will impact the dynamics of the market even further.
Across the globe, both children and adults are experiencing an increase in food allergies. With the increase in allergic diseases, it is likely that the demand for preventative and therapeutic measures for food allergies will increase. Additionally, 2/5th of the overall demand for allergy care is likely to be driven by an increased focus on research and development to offer advanced products to consumers.
In recent years, there has been an increase in allergies and awareness about food disorders that has forced the food industry and restaurants to follow regulatory norms in order to serve the nation. Gluten-free and dairy-free foods are an increase in demand on the market because both dietary programs and increasing awareness of food allergies among consumers have contributed to this demand.
Modern Medicine's Approach to Treat Food Allergies
The number of activities involved in research and development has increased over the past few years. Furthermore, the expansion of the market is largely due to the increased participation in research and development activities in the market. As a result, the food allergy market will have many opportunities for growth in the future. Drug approvals and launches will continue to drive the market's growth.
Food allergy market growth will also be positively impacted by increased investment in modern technologies and the emergence of new markets. In recent years, there has been a great deal of progress in understanding immunological mechanisms behind allergic disease, as well as a great deal of progress in identifying food allergens, which may lead to new therapeutic approaches. Researchers are currently looking into several forms of immunomodulation therapies, including peptide immunotherapy, mutant protein immunotherapy, allergy DNA vaccination, immunostimulatory DNA vaccination, and anti-immunoglobulin E (anti-IgE).
Principal Consultant
A lack of awareness regarding allergic conditions often leads to underdiagnosis and underestimation of these conditions, despite their high prevalence. In addition, inaccurate test results may negatively impact the growth of the food allergy market in the future.
A lack of uniformity in diagnostic criteria greatly limits the evidence for food allergy prevalence and management. Furthermore, the delay in the issuance of the results will negatively impact the growth of the market, as well as the fact that it involves a large volume of blood for multiple tests, which is hard for younger children and will hamper the growth.
A large price tag for the tests, as well as the absence of allergy tests, are the main concerns affecting the market. Despite this, organizations like the European Federation of Allergy and Airway Diseases Patients Associations (EFA) have introduced a lot of campaigns aimed at boosting food allergy awareness in the market.
New Entrants Bring Positive Changes to the Food Allergy Landscape
New entrants are capitalizing on technological advances in the food allergy field to introduce new solutions and gain a competitive edge in the market. These companies constantly invest in research and development to stay ahead of changing consumer preferences. The company is striving to advance the food allergy market and improve its position in the forum.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to the forecast, North America is likely to account for 43% of global food allergy treatments. Several factors are responsible for this dominance, including a large number of patients, advancements in food allergy treatment, and a high level of awareness regarding food allergies and treatment.
The development of new food allergy treatments and the development of new drugs in the USA market will further widen the market for food allergy treatments. As a result of the recent approval of oral immunotherapy (OIT) by the Food and Drug Administration (FDA), patients with peanut allergies can now benefit from this treatment, while patients with mild reactions are not suitable for this treatment.
A study published in JAMA Network Open Journal found that 10.8% of adults in the survey were food allergic, while nearly 17% believed they were. Food allergies are prevalent among nearly half of the adult population, and 38% of them have been to an emergency room as a result of food allergies.
Researchers at the American College of Allergy, Asthma, and Immunology (ACAAI) published a study in the scientific journal Annals of Allergy, Asthma, and Immunology that found targeted cognitive behavioral therapy (CBT) to significantly reduce anxiety associated with food allergies (FAA).
According to the estimate, the European region is expected to dominate the market. The revenue generated from this region accounts for 36% of the total revenue generated worldwide. Many people in the region suffer from allergies, which accounts for the region's dominance in the food allergy market. Food allergies affect over 150 million people worldwide, representing 20 percent of the region's population, according to the European Academy of Allergy and Clinical Immunology (EAACI).
Children and adults with food allergies are reported to be affected by food allergies at a rate ranging from 3-4%, respectively. Over 17 million Europeans suffer from allergies related to food, according to the European Academy of Allergy and Clinical Immunology. Over the past decade, the number of children who have been admitted to the hospital for severe reactions has increased by 7X.
In addition to minimizing the occurrence of food allergic reactions caused by undeclared allergens, the Joint Research Centre (JRC) of the European Commission has several other objectives. As Europeans become more aware of their allergies to certain foods and stricter compliance with regulatory requirements, the European food allergen testing market continues to grow.
Based on allergen sources, the market is segmented into gluten, peanut, mustard, milk, egg, fish, and other food allergy market. FMI predicts that peanuts allergen sources will dominate the market throughout the projection period. Peanut food allergy dominates more than 25% of the market.
The increasing prevalence of peanut allergies is a major factor driving the peanut allergy market. Furthermore, research is steadily being conducted to develop individual allergen immunotherapies (AIT) that can help in achieving allergen neutralization in less time with minimal side effects. Additionally, pharma and biotech companies are strongly inclining toward discovering new immunotherapies for peanut allergy, which is significantly driving the market growth.
In recent years, peanut allergy treatment and management have advanced dramatically. To desensitize an individual to allergens, new research is exploring oral immunotherapy, which gradually increases the amount of allergen a person is exposed to. A number of studies have also been conducted investigating the potential reduction in peanut allergy risk by using probiotics, allergen-specific immunotherapy, and gene therapy. A new diagnostic test that is more accurate and less invasive will be developed, as well as biomarkers specific to peanut allergy that can be located.
Food allergies are not uncommon. Approximately 17 million Europeans suffer from food allergies each year, of whom 3.5 million are under 25 years old, according to the European Federation of Allergy and Airways Diseases Patients Associations (EFA). Most children are allergic to peanuts and peanut allergy is the most common cause of food allergy death.
Based on treatment type, the food allergy market is segmented into antihistamines treatment. The oral immunotherapy segment is expected to represent 22% of the market and grow at a CAGR of 3.6% during the evaluation period. Research and development efforts are being conducted for the trials to develop proven methods for maximizing benefits and minimizing potential harm.
A strict avoidance of confirmed food allergens is recommended for the management of food allergy until food allergy OIT and other treatments have been proven to be reliable, safe, standardized, and approved for routine use in Australia (TGA) or New Zealand (Medsafe).
In childhood and adolescence with peanut allergy (PA), oral immunotherapy with Palforzia (POIT) aims to mitigate accidental allergic reactions. This therapy is a relatively new approach, so it's hard to know how many patients and families will choose it over strict avoidance.
Several domestic and regional players participate in the global food allergy market, which is highly fragmented and competitive. Mergers and acquisitions, expansions, collaborations, and partnerships are among the marketing strategies used by key players.
A company's marketing strategy can also be upscaled by developing new products. The implementation of these strategies has led to the development of advanced food allergy products.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 39.83 Billion |
| Market Value in 2033 | US$ 66.15 Billion |
| Growth Rate | CAGR of 5.2% from 2022 to 2032 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ Billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The food allergy market was worth US$ 38 Billion in 2022
According to FMI, the food allergy market will reach US$ 39.83 Billion by 2023.
From 2023 to 2033, FMI expects food allergy revenue to flourish at a 5.2% CAGR
In 2033, the food allergy market worth is poised to reach US$ 66.15 Billion
The North American market is expected to dominate the industry in 2023, accounting for more than 43% of overall revenues.
The food allergy market in Europe is expected to grow at a market share of 36% by 2033.
Allergy Therapeutics, Astellas Pharma, Inc., Immunomic Therapeutics, Inc., Prota Therapeutics, and Aimmune Therapeutics are the top 5 market players in the food allergy market.
According to forecasts, by 2032 food allergy sales in Asia Pacific will reach a market share of 22% during the forecast period.
1. Executive Summary | Food Allergy Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Allergen Source 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Allergen Source, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Allergen Source, 2023 to 2033 5.3.1. Gluten 5.3.2. Peanut 5.3.3. Mustard 5.3.4. Milk 5.3.5. Egg 5.3.6. Fish 5.3.7. Others 5.4. Y-o-Y Growth Trend Analysis By Allergen Source, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Allergen Source, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033 6.3.1. Antihistamines 6.3.2. Adrenaline 6.3.3. Oral Immunotherapy 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Treatment, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033 7.3.1. Clinics 7.3.2. Hospitals 7.3.3. Ambulatory Surgery Centers 7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. United States of America 9.2.1.2. Canada 9.2.2. By Allergen Source 9.2.3. By Treatment 9.2.4. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Allergen Source 9.3.3. By Treatment 9.3.4. By End-use 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Allergen Source 10.2.3. By Treatment 10.2.4. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Allergen Source 10.3.3. By Treatment 10.3.4. By End-use 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Allergen Source 11.2.3. By Treatment 11.2.4. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Allergen Source 11.3.3. By Treatment 11.3.4. By End-use 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Singapore 12.2.1.5. Thailand 12.2.1.6. Indonesia 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of Asia Pacific 12.2.2. By Allergen Source 12.2.3. By Treatment 12.2.4. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Allergen Source 12.3.3. By Treatment 12.3.4. By End-use 12.4. Key Takeaways 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Allergen Source 13.2.3. By Treatment 13.2.4. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Allergen Source 13.3.3. By Treatment 13.3.4. By End-use 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. United States of America 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Allergen Source 14.1.2.2. By Treatment 14.1.2.3. By End-use 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Allergen Source 14.2.2.2. By Treatment 14.2.2.3. By End-use 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Allergen Source 14.3.2.2. By Treatment 14.3.2.3. By End-use 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Allergen Source 14.4.2.2. By Treatment 14.4.2.3. By End-use 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Allergen Source 14.5.2.2. By Treatment 14.5.2.3. By End-use 14.6. United Kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Allergen Source 14.6.2.2. By Treatment 14.6.2.3. By End-use 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Allergen Source 14.7.2.2. By Treatment 14.7.2.3. By End-use 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Allergen Source 14.8.2.2. By Treatment 14.8.2.3. By End-use 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Allergen Source 14.9.2.2. By Treatment 14.9.2.3. By End-use 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Allergen Source 14.10.2.2. By Treatment 14.10.2.3. By End-use 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Allergen Source 14.11.2.2. By Treatment 14.11.2.3. By End-use 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Allergen Source 14.12.2.2. By Treatment 14.12.2.3. By End-use 14.13. Singapore 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Allergen Source 14.13.2.2. By Treatment 14.13.2.3. By End-use 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Allergen Source 14.14.2.2. By Treatment 14.14.2.3. By End-use 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Allergen Source 14.15.2.2. By Treatment 14.15.2.3. By End-use 14.16. Australia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Allergen Source 14.16.2.2. By Treatment 14.16.2.3. By End-use 14.17. New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Allergen Source 14.17.2.2. By Treatment 14.17.2.3. By End-use 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Allergen Source 14.18.2.2. By Treatment 14.18.2.3. By End-use 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2022 14.19.2.1. By Allergen Source 14.19.2.2. By Treatment 14.19.2.3. By End-use 14.20. Israel 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2022 14.20.2.1. By Allergen Source 14.20.2.2. By Treatment 14.20.2.3. By End-use 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Allergen Source 15.3.3. By Treatment 15.3.4. By End-use 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Allergy Therapeutics 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Astellas Pharma, Inc. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Immunomic Therapeutics, Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Prota Therapeutics 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Aimmune Therapeutics 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Aravax 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Cambridge Allergy Ltd 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. ALS Limited 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Charm Sciences 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Danaher Corporation 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Food Allergy Market
